|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | What do primary care physicians and researchers consider the most important patient safety improvement strategies显示文摘 | Gaal S Verstappen W Wensing M | 2011 | BMC Health Serv Res2011，11，1： | 1 |
| 2 | What do primary care physicians and researchers consider the most important patient safety improvement strategies 显示文摘 | Gaal S Verstappen W Wensing M | 2011 | BMC Health Ser- vices2011，11，1： | 1 |
| 3 | rRNA transcription and growth rate dependent regulation of ribosome synthesis in Escherichia coli 显示文摘 | Gourse R L Gaal T Bartlett M S | 1996 | Annu Rev Microbiol1996，50，1： | 1 |
| 4 | Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial显示文摘 | DIAMANT M van GAAL L STRANKS S et ol | 2010 | Lancet2010，375，9733： | 1 |
| 5 | Effects of Liraglutide in the treatment of obesity:a randomized,double- blind,placebo-controlled study显示文摘 | Astrup A RSssner S Van Gaal L | 2009 | Lancet2009，374，9701： | 1 |
| 6 | Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo- controlled study显示文摘 | Astrup A ROssner S Van Gaal L | 2009 | Lancet2009，374，9701： | 1 |
| 7 | On a conjectured ideal autocoirelation sequence and a re- lated triple error correcting cyclic code显示文摘 | Chang P Gaal S W Golomb G Gong T HeUeseth P V Ku- mar | 2000 | IEEE Tram Inform Theory2000，46，2： | 1 |
| 8 | Once weekly exenatidecompared with insulin glargine titrated to target in patients with type2 diabetes(DURATION-3): an open-label randomised trial显示文摘 | Diamant M Van Gaal L Stranks S | 2010 | Lancet2010，375，9733： | 1 |
| 9 | Determination of silver, palladium, and gold in some alloys by titrimetric methods and inductively coupled plasma atomic emission spectrometry显示文摘 | Abramovic B F Horrath K S Gaal F F | 1993 | Microchemical Journal1993，48，2： | 1 |
| 10 | Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study 显示文摘 | Astrup A Rfissner S Van Gaal L | 2009 | Lancet2009，374，9701： | 1 |
| 11 | Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study显示文摘 | Astrup A Rossner S Van Gaal L | 2009 | Lancet2009，374，9701： | 1 |
| 12 | Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study显示文摘 | Astrup A Rossner S Van Gaal L | 2009 | Lancet2009，374，9701： | 1 |
| 13 | Effects of liraglutide in the treatment of obesity: a randomised, double-blind,placebo-controlled study 显示文摘 | ASTRUP A ROSSNER S VAN GAAL L | 2009 | Lancet2009，374，9701： | 1 |
| 14 | Effects of liraglutide in the treatment of obesity:a randomized,double-blind,placebo-controlled study显示文摘 | Astrup A Rossner S Van Gaal L e t al | | 0，，9701： | 1 |
| 15 | Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial 显示文摘 | Diamant M Van Gaal L Stranks S | 2010 | Lancet2010，375，： | 1 |
| 16 | Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovas-cular risk factors in overweight patients:1-year experience from the RIOEurupe study显示文摘 | Van Gaal LF Rissanen AM Scheen A J Ziegler O Rossner S | 2005 | Lancet2005，365，9468： | 1 |
| 17 | Effects of liraglutide in the treatment of obesity : a randomised, double-blind, placebo-controlled study显示文摘 | Astrup A Rossner S Van Gaal L | 2009 | Lancet2009，374，： | 1 |
| 18 | Effects of liraglutide in the treatment of obesity:A randomised, doubleblind, placebocontrolled study 显示文摘 | Astrup A Rossner S Van Gaal L | 2009 | Lancet2009，374，： | 1 |
| 19 | Effects of liraglutide in the treatment of obesity:a randomised,doubleblind,placebo-controlled study显示文摘 | Astrup A Rossner S Van Gaal L | | 0，，9701： | 1 |
| 20 | Effects of li- raglutide in the treatment of obesity: a randomised, double- blind, placebo-controlled study 显示文摘 | ASTRUP A ROSSNER S VAN GAAL L | 2009 | Lancet2009，374，9701： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员